Literature DB >> 4037772

Cefotaxime diffusion into cerebrospinal fluid of children with meningitis.

B I Asmar, M C Thirumoorthi, J A Buckley, D M Kobos, A S Dajani.   

Abstract

Cefotaxime diffused consistently and in therapeutic levels into the cerebrospinal fluid (CSF) of 13 children successfully treated for bacterial meningitis. CSF cefotaxime levels early (6.0 micrograms/ml) and late (1.2 micrograms/ml) in treatment were severalfold the MBCs for the infecting organisms. After a single 40-mg/kg dose to each of five infants with ventriculostomies, mean CSF levels of cefotaxime were 6.4, 5.7, and 4.5 micrograms/ml at 2, 4, and 6 h, respectively.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037772      PMCID: PMC176325          DOI: 10.1128/AAC.28.1.138

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.

Authors:  J M Hamilton-Miller; W Brumfitt; A V Reynolds
Journal:  J Antimicrob Chemother       Date:  1978-09       Impact factor: 5.790

2.  Metabolism of cefotaxime in animals and man.

Authors:  J Chamberlain; J D Coombes; D Dell; J M Fromson; R J Ings; C M Macdonald; J McEwen
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

3.  HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin.

Authors:  R Wise; T Rollason; M Logan; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

4.  Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses.

Authors:  H C Neu; P Aswapokee; K P Fu; I Ho; C Matthijssen
Journal:  Clin Pharmacol Ther       Date:  1980-05       Impact factor: 6.875

5.  Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children.

Authors:  R E Kauffman; M C Thirumoorthi; J A Buckley; M K Aravind; A S Dajani
Journal:  J Pediatr       Date:  1981-12       Impact factor: 4.406

6.  Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis.

Authors:  W E Feldman; C M Ginsburg; G H McCracken; D Allen; P Ahmann; J Graham; L Graham
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

7.  Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics.

Authors:  D A Kafetzis; D C Brater; A N Kapiki; C V Papas; H Dellagrammaticas; C J Papadatos
Journal:  J Pediatr       Date:  1982-03       Impact factor: 4.406

8.  Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children.

Authors:  R E Kauffman; J N Miceli; L Strebel; J A Buckley; A K Done; A S Dajani
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

9.  Intravenous cefotaxime in children with bacterial meningitis.

Authors:  B H Belohradsky; K Bruch; D Geiss; D Kafetzis; W Marget; G Peters
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

10.  Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci.

Authors:  J L Weeks; E O Mason; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

View more
  14 in total

1.  Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.

Authors:  I R Friedland; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.

Authors:  M E Falagas; L McDermott; D R Snydman
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.

Authors:  C Doit; J Barre; R Cohen; S Bonacorsi; A Bourrillon; E H Bingen
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Cefotaxime versus chloramphenicol for ampicillin-resistant Haemophilus influenzae meningitis. A retrospective study of 62 cases.

Authors:  J R Lapointe; L Chicoine
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  Penetration of Cefotaxime into Cerebrospinal Fluid in Neonates and Young Infants.

Authors:  Xing-Kai Chen; Hai-Yan Shi; Stephanie Leroux; Hai-Yan Xu; Yue Zhou; Yi Zheng; Xin Huang; Yan Li; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

6.  Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.

Authors:  R F Jacobs; S L Kaplan; G E Schutze; A S Dajani; R J Leggiadro; C S Rim; S K Puri
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

Review 7.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

8.  Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.

Authors:  R Nau; H W Prange; P Muth; G Mahr; S Menck; H Kolenda; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

9.  Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.

Authors:  J M Trang; R F Jacobs; G L Kearns; A L Brown; T G Wells; F L Underwood; R B Kluza
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

Review 10.  Pharmacokinetics of anti-infective agents in paediatric patients.

Authors:  D R Butler; R J Kuhn; M H Chandler
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.